|
RHEB expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.161500E-04 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.8029199999936E-05 |
| Normal-vs-Stage2 |
1.086550E-01 |
| Normal-vs-Stage3 |
4.418400E-03 |
| Normal-vs-Stage4 |
9.359000E-01 |
| Stage1-vs-Stage2 |
2.666000E-01 |
| Stage1-vs-Stage3 |
5.875800E-01 |
| Stage1-vs-Stage4 |
3.824800E-03 |
| Stage2-vs-Stage3 |
5.413600E-01 |
| Stage2-vs-Stage4 |
1.836970E-01 |
| Stage3-vs-Stage4 |
2.315900E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.632000E-04 |
| Normal-vs-AfricanAmerican |
1.415860E-02 |
| Normal-vs-Asian |
7.479400E-01 |
| Caucasian-vs-AfricanAmerican |
9.329600E-01 |
| Caucasian-vs-Asian |
4.490800E-01 |
| AfricanAmerican-vs-Asian |
4.449400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.276340E-03 |
| Normal-vs-Female |
2.663400E-03 |
| Male-vs-Female |
9.872600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.262200E-01 |
| Normal-vs-Age(41-60Yrs) |
1.198790E-03 |
| Normal-vs-Age(61-80Yrs) |
1.863420E-03 |
| Normal-vs-Age(81-100Yrs) |
1.370430E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.345600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.478200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.522400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.650600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.742000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.610800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
7.822400E-03 |
| Normal-vs-Grade 2 |
2.233700E-04 |
| Normal-vs-Grade 3 |
5.389400E-04 |
| Normal-vs-Grade 4 |
7.083800E-01 |
| Grade 1-vs-Grade 2 |
5.753800E-01 |
| Grade 1-vs-Grade 3 |
4.805800E-01 |
| Grade 1-vs-Grade 4 |
1.189580E-01 |
| Grade 2-vs-Grade 3 |
7.697000E-01 |
| Grade 2-vs-Grade 4 |
1.454330E-02 |
| Grade 3-vs-Grade 4 |
2.052300E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
5.94039994972206E-09 |
| Normal-vs-ccB subtype |
4.409200E-01 |
| ccA subtype-vs-ccB subtype |
2.03269999999867E-05 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.298900E-03 |
| Normal-vs-N1 |
7.391800E-01 |
| N0-vs-N1 |
1.723590E-01 |
|
|
